Vontobel Holding’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Vontobel Holding’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,778	Closed	-$22.3K	–	1165
2024 Q1	$22.3K	Hold	2,778	–	–	﹤0.01%	1074
2023 Q4	$19.7K	Hold	2,778	–	–	﹤0.01%	1088
2023 Q3	$52K	Hold	2,778	–	–	﹤0.01%	1040
2023 Q2	$79K	Hold	2,778	–	–	﹤0.01%	1059
2023 Q1	$155K	Buy	+2,778	New	+$98.3K	﹤0.01%	1004

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DWS

Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vontobel Holding's TBIO Position: Q2 2024 in Review

Vontobel Holding sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 2,778 shares — an estimated $22.3K sold.

Vontobel Holding first reported a position in TBIO in Q1 2023 and held it in 5 quarters. The position peaked at $155K in Q1 2023. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

Vontobel Holding reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Vontobel Holding sold 2,778 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $22.3K.
Vontobel Holding first reported a position in Telesis Bio, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
Vontobel Holding's Telesis Bio, Inc. Common Stock position peaked at $155K in Q1 2023.
10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.